Global Imaging Capabilities RadMD provides comprehensive medical imaging services across over 80 countries with a network of more than 300 subspecialty-trained radiologists, presenting ample opportunities to expand partnerships with pharmaceutical and biotech companies seeking reliable international imaging solutions.

Oncology Expertise Specializing in oncology and multiple therapeutic areas, RadMD is well-positioned to attract clients in cancer research and personalized medicine who require high-quality imaging and centralized review services to enhance trial accuracy and regulatory compliance.

European Expansion Following recent European office openings in France and Western Europe, RadMD is expanding its footprint in EU markets, making it a strategic partner for local pharma and biotech companies aiming to streamline their clinical trial imaging processes.

Technology Stack Utilizing a modern tech stack including analytics, data management, and regulatory consulting tools offers sales prospects in providing integrated digital solutions that can elevate RadMD's service offerings and attract technologically forward clients.

Growth and Acquisition RadMD’s acquisition by Medica Group PLC in FY21 indicates increased financial stability and strategic growth potential, making it attractive for clients looking for a reliable and expanding imaging partner with a solid backing.